rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    NMTC
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      NeuroOne® Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF® Trigeminal Nerve Ablation System
      Oct 29Yahoo FinanceNMTC
      NeuroOne Featured in New York Post on OneRF® Patient’s Remarkable Journey to Overcome Debilitating Facial Pain
      Oct 27Yahoo FinanceNMTC
      NeuroOne secures first pharma order for drug delivery platform
      Oct 22Investing.comNMTC
      NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program
      Oct 22Yahoo FinanceNMTC
      NeuroOne receives $200,000 NIH subaward through April 2027
      Oct 8Investing.comNMTC
      NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology
      Oct 8Yahoo FinanceNMTC
      NeuroOne Reports Strong Fiscal 2026 Revenue Growth

      Detailed price information for Neuroone Medical Technologies Corp (NMTC-Q) from The Globe and Mail including charting and trades.

      Oct 6The Globe and MailNMTC
      NeuroOne reports preliminary Q4 revenue of $3.8 million
      Oct 6Investing.comNMTC
      NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
      Oct 5Yahoo FinanceNMTC
      NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement

      Agreement Covers Key Southern California Counties Including Los Angeles Metro as NeuroOne Broadens Commercial Access in Key U.S. MarketsEDEN PRAIRIE, Minn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on transforming the surgical diagnosis and treatment of neurological disorders, today announced a new Southern California distribution agreement for its FDA-cleared OneRF® Trigeminal

      Sep 17Yahoo FinanceNMTC
      NeuroOne at Moody Capital conference: thin-film platform aims for growth
      Sep 10Investing.comNMTC
      NeuroOne CBO David Wambeke buys $66,999 in company stock
      Sep 8Investing.comNMTC
      NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform

      Successful Large-Animal Procedures Build Momentum Toward Planned Launch of the StereoCED(TM) Platform for Human Investigational Clinical Studies Later This Quarter Related StereoCED(TM) Revenue Expected to be Recognized in the Current Fiscal Quarter ...

      Aug 27Yahoo FinanceNMTC

      This is the newest page. Registered accounts read further back.